Thymosin Alpha-1 Clinical Trials: How to Design a Robust Study Protocol
Learn how to design a rigorous thymosin alpha-1 clinical trial, covering patient selection, dosing, endpoints, blinding, statistics, and regulatory
Read articleFrom the lab.
Science-backed reads on peptide research, protocols, and compound data.
More articles
Statistical Power Analysis in Thymosin Alpha-1 Trial Design
Statistical power analysis determines sample sizes for Thymosin Alpha-1 trials. Learn how effect sizes and endpoints ...
Protocoles de contrôle par placebo dans les essais sur la Thymosine Alpha-1 : leçons méthodologiques des études récentes sur les peptides
Analyse des défis méthodologiques des essais contrôlés par placebo sur la thymosine alpha-1 : insu, choix du placebo,...
Blinding and Placebo Controls in GHRP-6 Trials
Blinding and placebo controls shape the validity of GHRP-6 trials. Subjective appetite endpoints are prone to unblind...
